Literature DB >> 34971720

Long-term outcomes after out-of-hospital cardiac arrest: A systematic review and meta-analysis.

Yip Han Chin1, Clyve Yu Leon Yaow1, Seth En Teoh1, Mabel Zhi Qi Foo2, Nan Luo3, Nicholas Graves4, Marcus Eng Hock Ong5, Andrew Fu Wah Ho6.   

Abstract

AIMS: Long term outcomes after out-of-hospital cardiac arrest (OHCA) are not well understood. This study aimed to evaluate the long-term (1-year and beyond) survival outcomes, including overall survival and survival with favorable neurological status and the quality-of-life (QOL) outcomes, among patients who survived the initial OHCA event (30 days or till hospital discharge).
METHODS: Embase, Medline and PubMed were searched for primary studies (randomized controlled trials, cohort and cross-sectional studies) which reported the long-term survival outcomes of OHCA patients. Data abstraction and quality assessment was conducted, and survival at predetermined timepoints were assessed via single-arm meta-analyses of proportions, using generalized linear mixed models. Comparative meta-analyses were conducted using the Mantel-Haenszel Risk Ratio (RR) estimates, using the DerSimonian and Laird model.
RESULTS: 67 studies were included, and among patients that survived to hospital discharge or 30-days, 77.3% (CI = 71.2-82.4), 69.6% (CI = 54.5-70.3), 62.7% (CI = 54.5-70.3), 46.5% (CI = 32.0-61.6), and 20.8% (CI = 7.8-44.9) survived to 1-, 3-, 5-, 10- and 15-years respectively. Compared to Asia, the probability of 1-year survival was greater in Europe (RR = 2.1, CI = 1.8-2.3), North America (RR = 2.0, CI = 1.7-2.2) and Oceania (RR = 1.9, CI = 1.6-2.1). Males had a higher 1-year survival (RR:1.41, CI = 1.25-1.59), and patients with initial shockable rhythm had improved 1-year (RR = 3.07, CI = 1.78-5.30) and 3-year survival (RR = 1.45, CI = 1.19-1.77). OHCA occurring in residential locations had worse 1-year survival (RR = 0.42, CI = 0.25-0.73).
CONCLUSION: Our study found that up to 20.8% of OHCA patients survived to 15-years, and survival was lower in Asia compared to the other regions. Further analysis on the differences in survival between the regions are needed to direct future long-term treatment of OHCA patients.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiac; Cardiac arrest; Long-term outcomes; OHCA; Out of hospital; Out-of-hospital cardiac arrest; Sudden cardiac arrest; Survival

Mesh:

Year:  2021        PMID: 34971720     DOI: 10.1016/j.resuscitation.2021.12.026

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  4 in total

1.  Association of High-Volume Centers With Survival Outcomes Among Patients With Nontraumatic Out-of-Hospital Cardiac Arrest: A Systematic Review and Meta-Analysis.

Authors:  Amelia Xin Chun Goh; Jie Cong Seow; Melvin Yong Hao Lai; Nan Liu; Yi Man Goh; Marcus Eng Hock Ong; Shir Lynn Lim; Jamie Sin Ying Ho; Jun Wei Yeo; Andrew Fu Wah Ho
Journal:  JAMA Netw Open       Date:  2022-05-02

Review 2.  Long-Term Outcomes after Non-Traumatic Out-of-Hospital Cardiac Arrest in Pediatric Patients: A Systematic Review.

Authors:  Zi Hui Celeste Ng; Siyuan Joseph Ho; Tan Caleb; Clyve Yu Leon Yaow; Seth En Teoh; Lai Peng Tham; Marcus Eng Hock Ong; Shu-Ling Chong; Andrew Fu Wah Ho
Journal:  J Clin Med       Date:  2022-08-26       Impact factor: 4.964

Review 3.  The Role of Drones in Out-of-Hospital Cardiac Arrest: A Scoping Review.

Authors:  Joseph Chun Liang Lim; Nicole Loh; Hsin Hui Lam; Jin Wee Lee; Nan Liu; Jun Wei Yeo; Andrew Fu Wah Ho
Journal:  J Clin Med       Date:  2022-09-28       Impact factor: 4.964

4.  Post-intensive care syndrome in out-of-hospital cardiac arrest patients: A prospective observational cohort study.

Authors:  Alessia Vincent; Katharina Beck; Emanuel Thommen; Madlaina Widmer; Christoph Becker; Nina Loretz; Sebastian Gross; Jonas Mueller; Simon A Amacher; Chantal Bohren; Rainer Schaefert; Jens Gaab; Stephan Marsch; Christian Emsden; Kai Tisljar; Raoul Sutter; Sabina Hunziker
Journal:  PLoS One       Date:  2022-10-14       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.